(Credit-Canva)
We all enjoy a good slushie every now and then. While they do not add any great nutritional value to our meal, they are a delightful snack made with shredded ice and sugar. To make them more accessible to people who cannot or do not wish to have sugar, there are many sugar free options to pick from. However, a recent study has revealed that sugar-free slushies containing glycerol, which is a sugar alcohol used to maintain their icy texture, can cause severe health problems in young children. The study was published in the journal Archives of Disease in Childhood, it explains that having these sugar free slushies can lead to children having a condition called "glycerol intoxication syndrome". In this condition there is a rapid drop in blood sugar, reduced consciousness, and a buildup of acid in the blood.
Kids who drank slushies with glycerol got sick very quickly. Within an hour, they started showing serious symptoms. Their blood sugar would plummet, sometimes dangerously low. Many became confused or lost consciousness, and some even had seizures. Doctors studied 21 children who got sick from these drinks between 2018 and 2024. Most of these kids were very young, seven years old or younger. By the time they got to the hospital, many were in bad shape, either unconscious or barely awake. This quick reaction time makes it especially scary, as parents might not realize the slushy is the cause right away. It's important to recognize these signs fast.
According to WebMD Glycerol is a type of naturally occurring alcohol, and it's used in lots of food products. You might find it in protein bars, diet foods, and even sugar-free candies. In slushies, it plays a key role in keeping the drink icy. Usually, slushies use tons of sugar to stop them from freezing completely. But because people are trying to cut back on sugar, companies are using glycerol instead. This is especially true in places with "sugar taxes," where sugary drinks cost more. So, to make sugar-free versions, they add glycerol. This switch means more kids are being exposed to this ingredient, which can be harmful to them.
The study explains that little kids are more at risk from glycerol because their bodies are still growing and developing. Their tiny bodies and young metabolisms might not be able to handle glycerol as well as adults' bodies can. This means that even a small amount can cause a big problem. Also, the amount of glycerol in a slushy can vary, and it's hard to know exactly how much is safe. Factors like how fast they drink it, if they've eaten recently, or if they've been exercising can also make a difference. Even the standard size of a slushy drink can be too much for a small child. This makes it hard to give a safe dose.
Health authorities in the UK and Ireland have already started warning about glycerol in slushies. They suggest that kids under four shouldn't have them at all, and older kids should only have one at most. But doctors are worried that these warnings might not be enough. They point out that it's hard to know how much glycerol is actually in each drink, making it difficult to give safe advice. Parents are being told to be very careful and consider avoiding these drinks altogether for young children. In the US, glycerol is approved for use in food, but parents should still be aware of the potential risks. More research is needed to understand the full impact.
Credit: iStock
India holds the record for the highest number of blind individuals in the entire world. The impact that the fact can have on those who hear it should be enough to cause them to stop dead in their tracks. The fact that it is preventable makes it all the more problematic, more than just a number. According to experts from AIIMS, New Delhi, more than 85% of blindness is preventable in the country, and not due to an incurable disease or insurmountable genetic condition.
The overwhelming majority of instances of blindness in India are due to a lack of glasses, or could be prevented by a surgical procedure lasting approximately 20 minutes. And yet, we are left with millions of blind people.
Preventable blindness refers to vision loss that could have been avoided through timely screening, treatment, correction, or surgical intervention. It is not the same as blindness caused by trauma, hereditary disorders, or conditions beyond medical reach.
The leading culprits in India are well-documented: cataract is responsible for 66.2% of all blindness cases, uncorrected refractive errors for 18.6%, glaucoma for 6.7%, and diabetic retinopathy for 3.3%. Every single one of these is either treatable or manageable with early detection.
Cataracts can be reversed in under thirty minutes. Refractive error can be corrected with spectacles that cost less than a meal at a restaurant. Diabetic retinopathy, if caught early, can be treated before it takes vision at all.
The tragedy of preventable blindness is not medical. It is systemic.
India carries one of the heaviest burdens of vision loss in the world, and the weight is only growing. There are disparities regarding the burden of vision loss. There are about 75% of the resources and health infrastructure that are found in urban locations whereas there are only 27% of the population and most of the hundreds of millions of people living in rural India do not have access to see an eye doctor because they would need to take a day off work without pay, travel over one hundred kilometers, and pay for the office bill in cash out-of-pocket.
Most people do not try to see an eye doctor, and when they do, it is usually too late to treat the problem.
At the same time, the problem has been exacerbated by the rapidly aging population of India and the incidence of age-related disorders increasing, such as cataracts and the diabetes epidemic, which is one of the largest in the world, has been causing a massive increase in diabetic retinopathy, which will cause continuing loss of vision without proper detection. These are not isolated cases but rather a direct result of the failure of the health care system in India to keep pace with the growing number of diseases in the population.
On the infrastructure side, the priority must be decentralization. Eye care cannot remain a service that lives primarily in urban hospitals. Vision screening needs to be integrated into primary health centers, school programs, and community outreach camps. The private sector, which runs over 70% of all eye care institutes in India, has a role, but so does public policy in incentivizing rural postings and strengthening district-level facilities.
On the workforce side, training mid-level ophthalmic personnel, optometrists, ophthalmic nurses, and vision technicians can extend the reach of a limited specialist pool significantly. Telemedicine-assisted models, where a technician in a rural camp transmits data to a city-based specialist for review, have already shown promise and need to be mainstreamed rather than treated as pilot experiments.
Early detection is arguably the most powerful lever of all. Most people in India visit an eye doctor only after vision loss is already severe. Routine screenings, especially for:
- Adults above 40
- People living with diabetes
- School-going children
Accessing vision care is not complicated. Availability is a major factor. Vision care must also be affordable to be accessible; currently, affordability is at the bottom of the list of priorities.
Examples of initiatives that have been implemented include subsidized cataract surgeries, free glasses for school children, free glasses for senior citizens, and community insurance models for eye care. All of these have been successful with valid results, and there’s plenty of evidence available that supports all these types of programs.
India can solve this. It has the necessary eye surgeon specialists, the model of care, and the evidence needed to make this happen. The issue preventing more people from receiving care, preventing blindness, which could be avoided, has always been a lack of awareness or attention to the problem to turn a statistic into an urgent need. At some point, we need to stop asking why this is happening and start asking why we will allow it to keep happening.
Credit: AI generated image
Although classified as a rare disease, hemophilia in India is widespread and overlooked. According to the World Federation of Hemophilia (WFH), about 75 percent of individuals affected by hemophilia are undiagnosed across the globe, hence lack proper healthcare, which is associated with an elevated incidence of complications.
In India, the gap is stark. The WFH has provided statistics that indicate that India has one of the largest hemophilia populations worldwide, with approximately 24,000 patients registered, whereas the estimated prevalence is approximately 1.2 lakhs, indicating that a large pool remains undiagnosed or outside the care pathway.
The implications of being undiagnosed or not receiving appropriate medical care are both clinical and non-clinical. Many people are losing milestones, dreams, or are otherwise negatively affected by the anxiety associated with living with an undiagnosed condition. For clinicians, this "hidden population" poses a daunting and deeply concerning challenge.
They are not missing; rather, they remain unseen due to delayed recognition, often presenting only after irreversible damage has already set in.
Children with persistent symptoms of joint swelling, unexplained excessive bleeding after sustaining minor injuries, and other symptoms are usually diagnosed with other health conditions, like bone injuries or nutrient deficiencies.
This period of clinical ambiguity can extend for months or even years before appropriate diagnostic testing and referrals are initiated.
Joint damage is often established by the time a conclusive diagnosis is made, and may lead to reduced mobility or early deformity, chronic pain, disability, and loss of functional independence. Severe complications, including intracranial hemorrhage, continue to pose significant risks in inadequately treated patients.
The barriers to timely diagnosis are both clinical and systemic, ranging from limited awareness and low suspicion among primary care providers to fragmented referral pathways and frequent misdiagnosis. At the systemic level, uneven access to the diagnostic infrastructure persists.
The availability of coagulation tests and specialists is mainly limited to the tertiary settings, thus posing a problem for patients from tier 2 and tier 3 regions. It is vital to understand the costs associated with a delay in diagnosis in the context of how far hemophilia care has evolved.
Over the past decade, advances in treatment have significantly improved patient outcomes. Clinical goals are no longer limited to managing bleeds as they occur, but to preventing them altogether, making “zero bleeds” an achievable reality. This is where prophylaxis takes centre stage.
Where on-demand therapy treats hemophilia symptoms only after a bleeding episode has occurred, prophylaxis seeks to prevent bleeding completely and is considered the gold standard of care globally. It can bring about reductions in bleeds by up to 90% and maintain healthy joints, allowing children to achieve near-normal musculoskeletal development.
When initiated early, prophylaxis can prevent the onset of joint damage. However, when patients are diagnosed late, they often enter care only after irreversible complications have already occurred. This makes early identification not just important, but decisive in altering disease trajectory.
Encouragingly, progress is visible. Several Indian states have demonstrated that publicly funded hemophilia programs, including access to prophylaxis and decentralized care models, can significantly improve patient outcomes. Initiatives that integrate early patient identification, diagnostic access, and coordinated care pathways are beginning to reduce delays and expand equitable access.
These state-led efforts offer important lessons for making prophylaxis the national standard of care in India. Recognizing hemophilia early and initiating prophylaxis in time is not just a clinical goal; it is the most critical step in changing the life course of these patients.

Credit: AI generated image
As summertime temperatures soar and heat waves become more frequent in many areas of the United States, physicians are seeing increasing numbers of patients experiencing an acute loss of kidney function due to heat-related illness. This phenomenon, known as heat-related acute kidney injury (AKI), is especially problematic when the prolonged high temperature of summer adds stress to the human body.
The most common cause of heat-related AKI is dehydration. When the body sweats excessively due to high temperatures, it loses a significant amount of fluid. If this fluid is not replaced, the blood volume in the body decreases.
The decrease in blood volume reduces blood flow to the kidneys. Because the kidneys depend on a continuous supply of blood to filter out waste products and assist with maintaining fluid balance, any decrease in blood flow to the kidneys can affect their ability to function properly. Ultimately, if the kidneys cannot function properly, they can develop serious problems, requiring medical intervention to reverse the problem.
Physicians on the ground have noted that specific population groups are more susceptible to extreme heat. Those working outdoors, such as construction workers, delivery people, and farmers, are particularly at risk because they are exposed to the sun for long periods of time. The elderly are more sensitive to heat because they have a lower ability to perceive thirst and conserve fluids than younger people. People who have pre-existing conditions such as diabetes, hypertension, and chronic kidney disease are also more likely than those without such conditions to develop complications from serious heat exposure.
An additional obstacle has been that the early signs of acute kidney injury (AKI) are often non-specific and may not be readily recognized by medical personnel. Symptoms include fatigue, dizziness, decreased urine output, nausea, and confusion; unfortunately, these types of symptoms tend to be dismissed as effects of heat exposure alone. By the time patients arrive at a medical facility for treatment, their AKI may have advanced to a more complicated state.
A further factor that may contribute to the development of AKI is the use of medications such as analgesics during the summer months. Analgesics may decrease blood flow to the kidneys; when taken during dehydration, they may further increase the risk of AKI. Therefore, it is essential to exercise caution when using medication during extreme summer heat.
Timely action and awareness play a major part in improving one’s chance of developing AKI from heat exposure. Drinking enough water (the most important step) cannot happen without adequate hydration; you must not wait for the sign of thirst to drink. Avoid outdoor activity in the hottest parts of the day, wear protective clothing, and take frequent breaks to help reduce the risk of developing AKI from heat stress.
Recognizing early signs of heat-related illness and getting prompt medical attention can help prevent permanent injury to your kidneys. As heatwaves continue to occur with more frequency, understanding the relationship between heat stress and kidney function is increasingly important for reducing the number of preventable kidney-related complications.
© 2024 Bennett, Coleman & Company Limited